Edward J. Kim, Edgar Ben-Josef, Joseph M. Herman, Tanios Bekaii-Saab, Laura A. Dawson, Kent A. Griffith, Isaac R. Francis, Joel K. Greenson, Diane M. Simeone, Theodore S. Lawrence, Daniel Laheru, Christopher L. Wolfgang, Terence Williams, Mark Bloomston, Malcolm J. Moore, Alice Wei and Mark M. Zalupski A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer Cancer 119
Version of Record online: 29 MAY 2013 | DOI: 10.1002/cncr.28117
Preoperative therapy with full-dose gemcitabine, oxaliplatin, and radiotherapy is feasible in patients with pancreatic cancer and results in a high percentage of complete resections. These results are particularly encouraging because the majority of patients had borderline resectable disease.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field